Altimmune (ALT) Return on Sales (2010 - 2025)
Altimmune (ALT) posted quarterly Return on Sales of 29.18% for Q4 2025, up 7554.0% year-over-year from 0.38% in Q4 2024, and up 176.72% quarter-over-quarter from 38.03% in Q3 2025.
Altimmune (ALT) Return on Sales (2010 - 2025) Analysis & Trends
Altimmune (ALT) has reported Return on Sales for 16 consecutive years, with 29.18% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Sales rose 7554.0% year-over-year to 29.18%; the TTM figure through Dec 2025 stood at 3.69% (up 5122.0% YoY), while the FY2025 annual figure was 3.69%, up 4124.0% from the prior year.
- Return on Sales improved to 29.18% in Q4 2025 per ALT's latest filing, from 38.03% in the prior quarter.
- Across five years, Return on Sales topped out at 29.18% in Q4 2025 and bottomed at 117.58% in Q3 2022.
- Historically, Return on Sales has averaged 24.3% across 5 years, with a median of 17.39% in 2022.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 11546 bps — and 2023, when it jumped 11701 bps.
- Altimmune's Return on Sales stood at 0.02% in 2021, then slumped by 22485 bps to 3.71% in 2022, then tumbled by 131 bps to 8.55% in 2023, then tumbled by 442 bps to 46.36% in 2024, then jumped by 163 bps to 29.18% in 2025.
- Business Quant data shows ALT's Return on Sales at 29.18% in Q4 2025, 38.03% in Q3 2025, and 44.29% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.18% |
| Sep 30, 2025 | -38.03% |
| Jun 30, 2025 | -44.29% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -46.36% |
| Sep 30, 2024 | -45.69% |
| Jun 30, 2024 | -49.28% |
| Mar 31, 2024 | -48.79% |
| Dec 31, 2023 | -8.55% |
| Sep 30, 2023 | -0.57% |
| Jun 30, 2023 | -28.16% |
| Mar 31, 2023 | -9.61% |
| Dec 31, 2022 | -3.71% |
| Sep 30, 2022 | -117.58% |
| Jun 30, 2022 | -25.17% |
| Mar 31, 2022 | -6.12% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -2.12% |
| Jun 30, 2021 | -1.81% |
| Mar 31, 2021 | -0.18% |